Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo.
[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
Treatment of Experimental Autoimmune Encephalomyelitis by Co-Delivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles.
Exploring the predictive value of the evoked potentials score in MS within an appropriate patient population: a hint for an early identification of benign MS?
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.
Commentary on 'Disability outcome measures in multiple sclerosis clinical trials'
The incidence of clinically isolated syndrome in a multi-ethnic cohort.
Neuroinflammatory changes negatively impact on LTP: A focus on IL-1β
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria.
Concise Review: Modeling Multiple Sclerosis With Stem Cell Biological Platforms: Toward Functional Validation of Cellular and Molecular Phenotypes in Inflammation-Induced Neurodegeneration.
STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
Unusual Presentation of Unilateral Isolated Probable Lyme Optic Neuritis.
The effect of rhythmic-cued motor imagery on walking, fatigue and quality of life in people with multiple sclerosis: A randomised controlled trial.
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Origins of oligodendrocytes in the cerebellum, whose development is controlled by the transcription factor, Sox9.
Neuropathic pain: diagnosis and treatment.
Central adaptation after optic neuritis: Is the whole greater than the sum of its parts?
[Natalizumab as induction therapy in multiple sclerosis.]
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Efficacy of statins in combination with interferon therapy in multiple sclerosis: A meta-analysis.
Fitness and cognitive processing speed in persons with multiple sclerosis: A cross-sectional investigation.
Fampridine improves severe dysarthria in secondary-progressive multiple sclerosis.
Effective communication at the point of multiple sclerosis diagnosis.
Teriflunomide and its mechanism of action in multiple sclerosis.

Pages